Coronavirus Alyson Kelvin covid-19 coronavirus canada vaccine Coronavirus Alyson Kelvin

USask’s VIDO-InterVac team collaborating with other universities to develop COVID-19 vaccine

VIDO-InterVac team is nearing human clinical trials for a COVID-19 vaccine being developed. They’re now collaborating with the University of Manitoba (U of M) and Dalhousie University to potentially speed up the process.Dalhousie researcher Alyson Kelvin specializes in emerging diseases.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News